acid (15), -sitosterol (16) and stigmasterol (17) were isolated from branches of Michelia champaca L. In addition, a cell proliferation assay of five of the isolated compounds on human breast and lung cancer cells showed that liriodenine (7) was the strongest inhibitor.
Breast cancer is the most common female cancer, comprising 23% of all cancers, with more than 1 million new cases per year. Effective chemopreventive treatments for breast cancer are still needed to increase available regimens and advance the efficacy of chemotherapy [1a-1c] . Lung cancer is one of the most common malignant and devastating of human tumors. Non-small cell lung cancer (NSCLC) A549 cells commonly develop resistance to radiation and chemotherapy [1d,1e] . Nevertheless, a great number of tumor histotypes show a low or very low response to such treatment, and only some display optimal results after its application. This is the main reason that the search for new anticancer compounds that are more effective against unresponsive tumors, with reduced adverse effects, is considered an important step in improving cancer chemotherapy [1f,1g] .
Michelia champaca L. is a large evergreen tree, native to South and Southeast Asia, which is primarily cultivated for its timber; its aril-covered seeds are highly attractive to birds [2a] . Previous phytochemical studies led to the isolation of ushinsunine, oxoushinsunine, magnoflorine, parthenolide, costunolide, dihydroparthenolide, michelinolide, 11,13-dehydrolanuginolide, magnograndiolide, michampanolide, quercetin, benzaldehyde 4-O-β-D-glucopyranoside, syringaresinol, and N-acetylanonaine [2b-2f] . To continue the search for novel agents from Magnoliaceous plants, the branches of M. champaca were chosen for the first time for phytochemical investigation. In this paper, we report the isolation of seventeen compounds, including six aporphines: (-)-anonaine (1) oxoaporphine: liriodenine (7) [2k]; one lignan: (+)syringaresinol (8) To evaluate the relative anticancer activity of liriodenine, vanillin, (-)-roemerine, (-)-N-acetylanonaine, and N-transferuloyltyramine, we investigated their proliferation inhibition effects in A549 human lung adenocarcinoma cells and MDA-MB-231 human breast adenocarcinoma cells. As shown in Figure 1 
Experimental
Cell culture and cell proliferation assay: A549 human lung adenocarcinoma cells and MDA-MB-231 human breast adenocarcinoma cells were cultured in Minimum essential medium supplemented with 10% FBS, 100 units/ mL of penicillin G, 100 µg/mL of streptomycin, and 0.25 µg/mL of amphotericin B (GIBCO BRL, Gaithersburg, MD, USA). All test compounds were dissolved in DMSO and stored at -20°C. Control cultures received the carrier solvent (0.1% DMSO). Cell proliferation was assessed by Premixed WST-1 Cell Proliferation Reagent (Clontech Laboratories Inc., Mountain View, CA, USA) according to the manufacturer's instructions.
Purification of active ingredients from M. champaca:
Michelia champaca L. was collected from Pingtung County, Taiwan in December, 2009. A voucher specimen was characterized by Dr Jin-Cherng Huang of the National Chiayi University, and deposited in Fooyin University, Kaohsiung County, Taiwan.
The air-dried branches of M. champaca (11.0 kg) were extracted with MeOH (80 L x 6) at room temperature and the MeOH extract (181.5 g) obtained after concentration under reduced pressure. This was chromatographed over silica gel (800 g, 70-230 mesh) using n-hexane/acetone as eluent to produce 5 fractions. These (supporting material) were subjected to repeated Si gel CC and preparative TLC to afford β-sitosterol (10.41 mg) and stigmasterol (6.67 mg) from fraction 1, liriodenine (12.53 mg), (-)-Nacetyl-anonaine (6.01 mg), scopoletin (4.42 mg), (+)syringaresinol (5.62 mg) and vanillin (4.35 mg) from fraction 2, vanillic acid (4.26 mg) from fraction 3,4acetonyl-3,5-dimethoxy-p-quinol (12.54 mg), syringic acid (15.03 mg), N-trans-feruloyltyramine (5.36 mg), N-cisferuloyltyramine (2.25 mg), and (-)-romerine (8.47 mg) from fraction 4, and (-)-anonaine (9.02 mg), (-)asimilobine (11.08 mg), (-)-nuciferine (6.71 mg) and (-)anolobine (5.37 mg) from fraction 5.
Supporting data: Detailed isolation procedure.
